Minimal hepatic encephalopathy (Q80105749)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18043677%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

review article

1 reference

title

Minimal hepatic encephalopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18043677%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

main subject

hepatic encephalopathy

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18043677%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Charmaine A Stewart

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18043677%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18043677%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Gastroenterology & Hepatology

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18043677%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18043677%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18043677%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

677-685

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18043677%20AND%20SRC:MED&resulttype=core&format=json

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Astrocyte-mediated control of cerebral blood flow

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Increased cerebrovascular resistance in cirrhotic patients with ascites.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

The role of glutamine in regulation of ammonium transport in Azotobacter vinelandii

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Role of the Escherichia coli glnALG operon in regulation of ammonium transport

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Feedback inhibition of ammonium (methylammonium) ion transport in Escherichia coli by glutamine and glutamine analogs

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Isolation of an ammonium or methylammonium ion transport mutant of Escherichia coli and complementation by the cloned gene.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Ammonia induces the mitochondrial permeability transition in primary cultures of rat astrocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Ammonia neurotoxicity: role of the mitochondrial permeability transition

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Induction of the mitochondrial permeability transition in cultured astrocytes by glutamine

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Glutamine-induced free radical production in cultured astrocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Oxidative stress in the pathogenesis of hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Ammonia neurotoxicity and the mitochondrial permeability transition

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Mechanisms of ammonia-induced astrocyte swelling

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Differential response of glutamine in cultured neurons and astrocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Glutamine in the mechanism of ammonia-induced astrocyte swelling

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

1 reference

7 January 2021

The brain glutamate system in liver failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Molecular mechanisms of the alterations in NMDA receptor-dependent long-term potentiation in hyperammonemia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Altered modulation of soluble guanylate cyclase in lymphocytes from patients with liver disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Neurologic manifestations in welders with pallidal MRI T1 hyperintensity

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Quality of life in cirrhotics with minimal hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Neuropsychological characterization of hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Neurophysiological assessment of early hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: clinical correlations

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Neuropsychological characterization and detection of subclinical hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

1 reference

7 January 2021

Neurobehavioral correlates of cholestatic and hepatocellular disease: differentiation according to disease specific characteristics and severity of the identified cerebral dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Bradykinesia in minimal hepatic encephalopathy is due to disturbances in movement initiation

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Neurological and neuropsychiatric syndromes associated with liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Neuropsychological abnormalities in cirrhosis include learning impairment.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Value of the critical flicker frequency in patients with minimal hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Reduction of Cerebral Blood Flow in Subclinical Hepatic Encephalopathy and its Correlation with Plasma-Free Tryptophan

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Regional cerebral blood flow and cognitive function in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Cerebral magnetic resonance imaging in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Clinical correlation of neuropsychological tests with 1H magnetic resonance spectroscopy in hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Correlations between cerebral glucose metabolism and neuropsychological test performance in nonalcoholic cirrhotics

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Assessment of utilities and health-related quality of life in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Subclinical hepatic encephalopathy impairs daily functioning

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Screening of subclinical hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Factors associated with poor health-related quality of life of patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Minimal hepatic encephalopathy impairs fitness to drive

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Prognostic significance of hepatic encephalopathy in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Subclinical hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Minimal hepatic encephalopathy: longitudinal effects of liver transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Incomplete improvement of visuo-motor deficits in patients with minimal hepatic encephalopathy after liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Encephalopathy and neuropathy in end-stage liver disease before and after liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Involvement of selenoprotein P in protection of human astrocytes from oxidative damage.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0999

7 January 2021

Identifiers

DOI

10.1038/NCPGASTHEP0999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18043677%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18043677%20AND%20SRC:MED&resulttype=core&format=json